Comparison Overview

Biotron Laboratories, Inc. (now Actylis)

VS

Eastman

Biotron Laboratories, Inc. (now Actylis)

750 North 120 West, Centerville, 84014, US
Last Update: 2026-04-03
View Profile
Between 750 and 799
https://www.actylis.com

Actylis was created from the merger of eight experienced specialty manufacturing companies and three sourcing firms, integrated into a single entity. Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and AgriScience industries. Actylis' Nutrition division specializes in manufacturing mineral amino acid chelates and complexes. Our goal is to provide our corporate customers top-tier service and continual product improvement resulting in premium materials. To accomplish these goals, we rely on a depth of experience, a rigorous approach to product quality and emphasize both scientific validation and integrity.

NAICS: 325
NAICS Definition: Chemical Manufacturing
Employees: 18
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Eastman

200 South Wilcox Drive, Kingsport, Tennessee, US, 37662
Last Update: 2026-03-27
Between 750 and 799
http://www.eastman.com

Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company’s innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end markets such as transportation, building and construction, and consumables. As a globally inclusive company, Eastman employs approximately 14,000 people around the world and serves customers in more than 100 countries. The company had 2024 revenue of approximately $9.4 billion and is headquartered in Kingsport, Tennessee, USA.

NAICS: 325
NAICS Definition: Chemical Manufacturing
Employees: 10,838
Subsidiaries: 8
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/biotron-laboratories-inc..jpeg
Biotron Laboratories, Inc. (now Actylis)
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/eastman.jpeg
Eastman
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Biotron Laboratories, Inc. (now Actylis)
100%
Compliance Rate
0/4 Standards Verified
Eastman
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Chemical Manufacturing Industry Average (This Year)

No incidents recorded for Biotron Laboratories, Inc. (now Actylis) in 2026.

Incidents vs Chemical Manufacturing Industry Average (This Year)

No incidents recorded for Eastman in 2026.

Incident History — Biotron Laboratories, Inc. (now Actylis) (X = Date, Y = Severity)

Biotron Laboratories, Inc. (now Actylis) cyber incidents detection timeline including parent company and subsidiaries

Incident History — Eastman (X = Date, Y = Severity)

Eastman cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/biotron-laboratories-inc..jpeg
Biotron Laboratories, Inc. (now Actylis)
Incidents

No Incident

https://images.rankiteo.com/companyimages/eastman.jpeg
Eastman
Incidents

No Incident

FAQ

Eastman company demonstrates a stronger AI Cybersecurity Score compared to Biotron Laboratories, Inc. (now Actylis) company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Eastman company has disclosed a higher number of cyber incidents compared to Biotron Laboratories, Inc. (now Actylis) company.

In the current year, Eastman company and Biotron Laboratories, Inc. (now Actylis) company have not reported any cyber incidents.

Neither Eastman company nor Biotron Laboratories, Inc. (now Actylis) company has reported experiencing a ransomware attack publicly.

Neither Eastman company nor Biotron Laboratories, Inc. (now Actylis) company has reported experiencing a data breach publicly.

Neither Eastman company nor Biotron Laboratories, Inc. (now Actylis) company has reported experiencing targeted cyberattacks publicly.

Neither Biotron Laboratories, Inc. (now Actylis) company nor Eastman company has reported experiencing or disclosing vulnerabilities publicly.

Neither Biotron Laboratories, Inc. (now Actylis) nor Eastman holds any compliance certifications.

Neither company holds any compliance certifications.

Eastman company has more subsidiaries worldwide compared to Biotron Laboratories, Inc. (now Actylis) company.

Eastman company employs more people globally than Biotron Laboratories, Inc. (now Actylis) company, reflecting its scale as a Chemical Manufacturing.

Neither Biotron Laboratories, Inc. (now Actylis) nor Eastman holds SOC 2 Type 1 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Eastman holds SOC 2 Type 2 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Eastman holds ISO 27001 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Eastman holds PCI DSS certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Eastman holds HIPAA certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Eastman holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Published
Date
2026-04-02
Updated
Date
2026-04-02
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References